Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

2.3K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temporal trends in semen parameters among men attending a fertility center in the UAE (2012 - 2022): a retrospective study.

Frontiers in physiology·2026
Same author

Clinicopathological features and ethnic disparities of melanoma in the United Arab Emirates: 2017-2025.

PloS one·2026
Same author

Advancing Academic Gastroenterology: Reflections From a Social Media Ambassador for ACG Case Reports Journal.

ACG case reports journal·2026
Same author

Vasectomy revisited: Safe procedure in a changing reproductive landscape.

International journal of impotence research·2026
Same author

Vasectomy at a crossroads: utilization, equity, and clinical practice in a changing reproductive landscape.

International journal of impotence research·2026
Same author

Incidence of Sepsis After Transrectal Ultrasound-Guided Prostate Biopsy in Dubai Tertiary Care Hospitals: A Multicenter Cohort Study.

Cureus·2026

Related Experiment Video

Updated: Oct 15, 2025

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.5K

Rezum Therapy for Benign Prostatic Hyperplasia: Dubai's Initial Experience.

Rashed Rowaiee1, Aya Akhras1, Jeyaseelan Lakshmanan2

  • 1Urology, Mohammed Bin Rashid University of Health and Medical Sciences, Dubai, ARE.

Cureus
|October 25, 2021
PubMed
Summary
This summary is machine-generated.

Rezum therapy offers a safe and effective minimally invasive treatment for symptomatic benign prostatic hyperplasia (BPH). This study in Dubai shows significant improvements in urinary flow and reduced residual volume, enhancing patient quality of life.

Keywords:
benign prostatic hyperplasialower urinary tract symptomsminimally invasivetransurethral radiofrequency thermal ablationwater vapor therapy

More Related Videos

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.4K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.1K

Related Experiment Videos

Last Updated: Oct 15, 2025

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.5K
Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser
05:28

Enucleation of the Prostate for the Treatment of Benign Prostatic Hyperplasia Using a 980 nm Diode Laser

Published on: May 5, 2020

2.4K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.1K

Area of Science:

  • Urology
  • Minimally Invasive Surgery
  • Men's Health

Background:

  • Symptomatic benign prostatic hyperplasia (BPH) significantly impacts quality of life for middle-aged men.
  • Current treatments (pharmacologic, invasive) have variable effectiveness and side effects.
  • Rezum therapy presents a novel, minimally invasive option for BPH management.

Purpose of the Study:

  • To evaluate the efficacy and safety of Rezum therapy for symptomatic BPH.
  • To report the initial outcomes of Rezum treatment in Dubai, UAE.
  • To compare Rezum's outcomes with existing BPH treatment modalities.

Main Methods:

  • Retrospective analysis of 49 patients with symptomatic BPH treated with Rezum.
  • Assessment of prostate volume, pre- and post-operative post-void residual (PVR), and peak urinary flow (Qmax).
  • Evaluation of safety, side effects, and follow-up parameters over a mean of three months.

Main Results:

  • Significant improvement in Qmax (8.11 ml/s, p=0.001) and reduction in PVR (94.32 cm³, p=0.001) post-Rezum therapy.
  • No significant variation in Qmax and PVR changes based on initial prostate volume.
  • Rezum demonstrated a favorable safety profile with low rates of sexual dysfunction compared to TURP or medical therapy.

Conclusions:

  • Rezum therapy is a safe, effective, and minimally invasive treatment for symptomatic BPH.
  • The procedure offers comparable outcomes to trans-urethral resection of the prostate (TURP) with improved quality of life.
  • Further long-term studies are recommended to assess Rezum's implications up to five years post-operatively.